Induction of Neutrophilic Traps ( NETs ) by the Environment and Infectious Inflammatory Lung Cystic Fibrosis
NCT02564393 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2015-09-30
Summary
The study is defined in 3 stages of in vitro assays :
Phase 1 : Secretion of NETs in response to lung disease and their secretion of factors.
This is a transversal study in which we compare :
* Producing NETs (DNA and proteases ) by neutrophils purified from sputum and blood of patients
* Producing NETs (DNA and proteases ) by purified neutrophils in the blood of patients and blood of control subjects
Phase 2: Mechanisms of activation of NETs secretory pathways . This phase will identify receptors (TLR ) involved in the secretion of NETs and analyze the involvement of dependent transduction pathways calcium and PKC . It will be performed on control blood neutrophils.
Phase 3: Analysis of cell death ( NETose )
This is a transversal study that will analyze :
the mode of cell death of neutrophils purified blood and sputum of patients and control blood neutrophils by flow cytometry and transmission electron microscopy .
Conditions
Sponsors & Collaborators
-
University Hospital, Tours
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2013-05-31
Countries
- France
Study Locations
More Related Trials
-
Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging
NCT00023465 ·Status: UNKNOWN
-
Characterization of Pulmonary Microbiome in Cystic Fibrosis Patients
NCT04735679 ·Status: UNKNOWN
-
Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis Patients
NCT02550041 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Nebulization and Positive Expiratory Pressure Combination
NCT02535130 ·Status: UNKNOWN ·Phase: NA
-
Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients
NCT02421120 ·Status: COMPLETED ·Phase: PHASE4
-
Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.
NCT02309229 ·Status: COMPLETED
-
Inflammatory and Microbiologic Markers in Sputum: Comparing Cystic Fibrosis With Primary Ciliary Dyskinesia
NCT01155115 ·Status: COMPLETED ·Phase: NA
-
Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis
NCT00721071 ·Status: COMPLETED ·Phase: PHASE2
-
Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis
NCT02308267 ·Status: UNKNOWN
-
Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus
NCT05101915 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Simvastatin on CF Airway Inflammation
NCT00255242 ·Status: COMPLETED ·Phase: PHASE1
-
Implication of UNconventionaL T Lymphocytes in Cystic Fibrosis (UNLOCk)
NCT03886350 ·Status: COMPLETED
-
Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation
NCT02480270 ·Status: COMPLETED
-
Anti-IL5 and Other Biotherapies in Cystic Fibrosis
NCT04256772 ·Status: UNKNOWN
-
Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
NCT00004296 ·Status: COMPLETED
-
Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified
NCT02526004 ·Status: COMPLETED ·Phase: NA
-
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
NCT01661491 ·Status: COMPLETED
-
Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.
NCT03312075 ·Status: TERMINATED
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED
-
DNA Methylation and Lung Disease in Cystic Fibrosis
NCT02884622 ·Status: COMPLETED ·Phase: NA
-
The Infective Pulmonary Exacerbations in Cystic Fibrosis - an Ecological Perspective
NCT01306279 ·Status: COMPLETED
-
T Cell Memory Fuels the Innate Response in Chronic CF Lung Disease
NCT04397861 ·Status: COMPLETED
-
COVID-19 Antibody Responses In Cystic Fibrosis
NCT05158829 ·Status: UNKNOWN
-
Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria
NCT05686837 ·Status: ENROLLING_BY_INVITATION
-
Taste Receptors Regulation in CF Patients
NCT04058340 ·Status: UNKNOWN ·Phase: NA